1. Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer


    Xi Su et al, 2020, OncoTargets and Therapy CrossRef
  2. Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
    Silvia Martina Ferrari et al, 2018, Frontiers in Endocrinology CrossRef
  3. Is Melanoma Progression Affected by Thyroid Diseases?
    Salvatore Ulisse et al, 2022, International Journal of Molecular Sciences CrossRef
  4. Papillary Thyroid Cancer Prognosis: An Evolving Field
    Salvatore Ulisse et al, 2021, Cancers CrossRef
  5. The Changing Face of in vitro Culture Models for Thyroid Cancer Research: A Systematic Literature Review
    Dylan Chew et al, 2020, Frontiers in Surgery CrossRef
  6. Lenvatinib-induced severe interstitial pneumonia in a patient with hepatocellular carcinoma: A case report
    Yuki Ikeda et al, 2021, Kanzo CrossRef
  7. Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma
    Laurys Boudin et al, 2022, Current Oncology CrossRef
  8. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics
    Ichiro Abe et al, 2021, Current Oncology Reports CrossRef
  9. Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
    Takuya Sho et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
  10. Advanced Differentiated Thyroid Cancer: A Complex Condition Needing a Tailored Approach
    Antonio Mario Bulfamante et al, 2022, Frontiers in Oncology CrossRef